Genetic association of non-MHC region with ankylosing spondylitis in a Chinese population.

Jing Liu,Weilin Pu,Yuan Li,Yanyun Ma,Qi Zhu,Wei Wan,Chengde Yang,Xiaofeng Wang,Xingdong Chen,Xiaodong Zhou,John D Reveille,Li Jin,Hejian Zou,Jiucun Wang
DOI: https://doi.org/10.1136/annrheumdis-2018-214625
IF: 27.973
2019-01-01
Annals of the Rheumatic Diseases
Abstract:Ankylosing spondylitis (AS) is a chronic inflammatory disease mainly affecting the sacroiliac joints and spine.1 order to examine overall genetic susceptibility of AS, several genome-wide association studies (GWASs) were performed in Caucasian populations, and a number of genetic polymorphisms in non-major histocompatibility complex (MHC) regions were found, such as ERAP1 , IL23R as well as many others.2–6 However, only a small portion of the single nucleotide polymorphisms (SNPs) were validated in East Asian (EA) populations.2 recent years, multiple studies indicated significant genetic differences between different European and EA populations.2 7 To resolve this further, we have examined all reported AS-associated SNPs in non-MHC regions in Chinese patients with AS. A total of 1289 patients with AS and 1536 controls were included in this analysis, which have not been included in prior analyses.2 7 The sociodemographic and clinical characteristics of the cohort are presented in online supplementary table S1.### Supplementary data[annrheumdis-2018-214625-supp1.docx] In this study, the candidate SNPs were mainly selected from six GWAS studies published from 2007 to 2016.2–6 8 Overall, 69 …
What problem does this paper attempt to address?